Stocks · Health care · Pharmaceutical Preparations

Johnson & Johnson

JNJ Clue Score64
United States Fiscal year ends January CIK 0000200406 Results filed 13 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
John G Morikis
26 Nov 2025
Director
Buy
1,250
$206.15
$257.69K
Mark A Weinberger
12 Dec 2024
Director
Buy
1,000
$147.22
$147.22K
Showing 250 of 433 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 562
Amendments (4/A) skipped 2
Filings about a different issuer 12
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 163
Sales at will 246
Transactions with no price 0
Shares from compensation/vesting 9,708,544
Sales filed before the plan box existed 235
History held since 3 Oct 2006